EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,659 | -56.2% | 298,145 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $51,728 | +34.3% | 298,145 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $38,520 | -21.1% | 298,145 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $48,806 | -20.0% | 298,145 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $61,000 | -18.7% | 298,145 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $75,000 | -41.4% | 298,145 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $128,000 | -51.1% | 298,145 | 0.0% | 0.00% | -40.0% |
Q4 2021 | $262,000 | -25.1% | 298,145 | +36.5% | 0.01% | -28.6% |
Q3 2021 | $350,000 | – | 218,447 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MMCAP International Inc. SPC | 145,941 | $18,856 | 0.00% |
ARISTEIA CAPITAL, L.L.C. | 1,540,297 | $153,106 | 0.00% |
Sea Otter Advisors LLC | 25,000 | $3,230 | 0.00% |
LITTLEJOHN & CO LLC | 16,666 | $2,153 | 0.00% |
WHITEBOX ADVISORS LLC | 298,145 | $38,520 | 0.00% |
Citadel Advisors | 27,743 | $3,584 | 0.00% |
III Capital Management | 41,795 | $4,154 | 0.00% |
Tower Research Capital LLC (TRC) | 23 | $0 | 0.00% |
Parallel Advisors, LLC | 64,166 | $4,812 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |